hapbee

Adding Hapbee Tech (HAPB, HAPBF) $0.34 to Biotech Six Pack Watch List.

UPDATE ON BIOTECH SIX PACK, SIX STOCKS WE EXPECT TO DOUBLE. While the Biotech Stock Review was launched...
Internet Stock Review

Peleton (PTON) Hits $25 Billion Valuation. Calm (Private) Hits Unicorn Valuation at $1 Billion.

Home Fitness and Wellness Raging on Main Street and Wall Street. While 24 Hour Fitness Files for Bankruptcy..
Teledoc, Biotech Stock Review

Nothing Quite Like Telehealth. Teledoc (TDOC) Price Targets Raised.

A number of recent price target changes have been made on Teladoc Health, including: Piper Sandler raises target price...

Kevin Harrington Presentation. (Video)

The Three Strategies I've Used to Build Businesses. https://youtu.be/aNZAAKxPNlM Shark Tanks’ Kevin...

Digital Coaches at Dario (DRIO) Significantly Reduce Depression.

63% of Users Show Significant Improvement After Impact of Digital Coaching and Breathing Exercises as Part of the Dario Health Platform.
CB Scientific, Biotech Stock Review, Telehealth

Report: My-Cam™ and My-Cardia™ the Ultimate ‘Any-Doctor-Anywhere’ Telehealth Monitoring Application.

New and Updated Report on CB Scientific (CBSC) $1.05. Revolutionary Any-Doctor-Any Where, at Home Heart Rate Monitor, can...
Hea;thLynked, Biotech Stock Review

Up 191%, HealthLynked (HLYK) Reporting Decent Numbers.

Up as much as 417% from where we added it to the Watch List, the Company continues to report increasing revenues while...
Hapbee

Adding Hapbee (HAPB) to the Watch List.

Listed on TSX under HAPB, we're officially price and time stamping our interest in this amazing little technology Company by adding it...

True Nature|Mitesco (TNTY). Coverage Report Issued.

Record Volume and Gradually Rising Price Portends to Higher Prices in 2020 as True Nature Executes on Recently Announced Incubator Strategy.
CB Scientific, Biotech Stock Review

Adding Telehealth Play CB Scientific (CBSC) $1.10 to CoronaVirus Watch List.

MyCardia's My-Cam Offers At-Home Heart Rate Monitoring. LIVE QUOTE

Latest article

Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.

DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!

Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.

CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...